comparemela.com

Latest Breaking News On - Peter leys - Page 3 : comparemela.com

Materialise NV (NASDAQ:MTLS) Q4 2022 Earnings Call Transcript

Operator: Good day and thank you for standing by. Welcome to the Q4 2022 Materialise NV Financial Results Conference Call. Please be advised that today s conference is being recorded.

Georgia
United-states
Paris
France-general
France
Ukraine
Ukrainian
Jody-burfening
Johan-albrecht
Troy-jensen
Your-software
Biggest-georgia-companies

Why Materialise Stock Was Falling on Tuesday

Investors are looking for balance of top- and bottom-line growth in this environment.

Ukraine
Peter-leys

Materialise Reports Fourth Quarter and Full Year 2022 Results

Materialise Reports Fourth Quarter and Full Year 2022 Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Leuven
Region-flamande
Belgium
Kyiv
Kyyiv
Misto
Ukraine
Russia
Johan-albrecht
Wilfried-vancraen
Exchange-commission
Materialise-software

Materialise Reports Third Quarter 2022 Results

27.10.2022 - Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing and medical software and of sophisticated 3D printing services, today announced its financial results for the third quarter ended September 30, 2022. Highlights – Third .

Ukraine
Belgium
Johan-albrecht
Wilfried-vancraen
Exchange-commission
Materialise-software
Exchange-rate
European-central-bank-on
Securities-exchange
Nasdaq
Chairman-peter-leys
Materialise-medical

Materialise NV: Materialise Reports Third Quarter 2022 Results

Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing and medical software and of sophisticated 3D printing services, today announced its financial results for the third quarter

Ukraine
Belgium
Johan-albrecht
Wilfried-vancraen
Exchange-commission
Materialise-software
Exchange-rate
European-central-bank-on
Securities-exchange
Third-quarter
Chairman-peter-leys
Materialise-medical

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.